MIZORIBINE

SynDRA canonical compound SYN0007416 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	IMPDH1
Mechanism of action	immunosuppressant \| inosine monophosphate dehydrogenase inhibitor
Indication	nephrotic syndrome \| organ rejection
Disease area	rheumatology \| transplant

All known targets

bredinin
beta-Bredinin
Mizoribina
Bredinin
NSC-289637
Bredinine
MZR
Mizoribinum
M 3047
Bredinin (TN)
HE-69
HS-0046
Mizoribina [INN-Spanish]
Mizoribine [INN:JAN]
Mizoribinum [INN-Latin]
Mizoribine (JAN/INN)
Bredinin, HE 69, NSC 289637, MZB, Mizoribine
Anhydro-4-carbamoyl-5-hydroxy-1-beta-D-ribofuranosyl-imidazolium hydroxide
N'-(beta-D-Ribofuranosyl)-5-hydroxyimidazole-4-carboxamide
N'-(beta-D-Ribofuranosyl)-5-hydroxy-imida-zole-4-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide;4-Carbamoyl-1-beta-D-ribofuranosyl-imidazolium-5-olate
4-carbamoyl-1-b-d-ribofuranosylimidazolium-5-olate
5-Hydroxy-1-beta-D-ribofuranosyl-1H-imidazole-4-carboxamide
5-Hydroxy-1-beta-D-ribofuranosylimidazole-4-carboxamide
4JR41A10VP
NSC 289637
DTXCID6025777
RefChem:819016
HE 69
MFCD00057221
MLS000028813
SMR000058473
1H-Imidazole-4-carboxamide, 5-hydroxy-1-b-D-ribofuranosyl-
NCGC00094087-01
CAS-50924-49-7
Mizoribine Hydrobromide
SR-01000075989
BRN 4151713